Lisa Carlson

Artiklar

Article: CHRONIC RESPIRATORY DISEASE. 2024;21:14799731241299443
Antifibrotic drug treatment of patients with idiopathic pulmonary fibrosis in Sweden: A registry-based observational study
Carlson L; Kalafatis D; Pesonen I; Magnusson JM; Skold M
Article: RESPIROLOGY. 2021;26(10):982-988
Outcomes of patients with advanced idiopathic pulmonary fibrosis treated with nintedanib or pirfenidone in a real-world multicentre cohort
Durheim MT; Bendstrup E; Carlson L; Sutinen EM; Hyldgaard C; Kalafatis D; Myllarniemi M; Skold CM; Sjaheim T
Article: RESPIRATORY RESEARCH. 2021;22(1):40
Baseline characteristics and survival of patients of idiopathic pulmonary fibrosis: a longitudinal analysis of the Swedish IPF Registry
Gao J; Kalafatis D; Carlson L; Pesonen IHA; Li C-X; Wheelock A; Magnusson JM; Skold CM
Article: BMC PULMONARY MEDICINE. 2019;19(1):222
Gender differences at presentation of idiopathic pulmonary fibrosis in Sweden
Kalafatis D; Gao J; Pesonen I; Carlson L; Skold CM; Ferrara G
Article: MULTIDISCIPLINARY RESPIRATORY MEDICINE. 2018;13:14
Delay and inequalities in the treatment of idiopathic pulmonary fibrosis: the case of two Nordic countries
Pesonen I; Carlson L; Murgia N; Kaarteenaho R; Skold CM; Myllarniemi M; Ferrara G